Dates:

01/05/2017 to 30/04/2019

Overview and Aims:

To clinically validate the predictive value of the Play.Care assessement for autism for medical market entry and uptake with Phase 3 Diagnostic Clinical Trials set within a multi-site study of children already diagnosed with ASD in the United Kingdom and Sweden.

Consortium Website:

https://www.strath.ac.uk/research/innovationinautism/projectscollaborations/ 

 

Project Partners:

University of Strathclyde (Consortium Lead)

University of Aberdeen

University of Glasgow

University of Gothenburg

 

Funder:

Horizon 2020 SME Instrument to Harimata 

https://ec.europa.eu/programmes/horizon2020/en/what-horizon-2020